Keyphrases
BRCA2 mutation
58%
Breast Cancer Susceptibility Gene 1 (BRCA1)
46%
BRCA2
44%
Ovarian Cancer Risk
42%
Ovarian Cancer
39%
Single nucleotide Polymorphism
35%
MLH1
33%
Blau Syndrome
33%
Breast
33%
Breast Cancer
27%
Sarcoidosis
23%
MSH2
22%
BRCA1, BRCA2
22%
Breast Cancer Risk
21%
BRCA mutation Carriers
20%
Inuit
19%
Cause of Disease
19%
Common Genetic Variants
18%
BRCA mutation
18%
Lynch Syndrome
18%
Missense Variants
18%
RNA-binding Protein
16%
Danes
16%
Dwarfism
16%
Greenlandic Inuit
16%
Ancient Humans
16%
Paleoeskimo
16%
Molecular Characterization
16%
Intronic mutation
16%
Recruitment Domain
16%
Insulin-like Growth Factor 2 (IGF2)
16%
Penetrance
16%
Colorectal Cancer Patients
16%
Gene-deficient Mice
16%
Functional Assessment
16%
Von Hippel-Lindau Disease
16%
Gut Development
16%
Safe House
16%
MicroRNA Dysregulation
16%
Susceptibility Loci
16%
Exon 4
16%
MSH6
16%
Cancer Families
16%
Genetic Variation
16%
Tumor
16%
Monozygotic Twins
16%
Caspase
16%
Molecular Subtypes
16%
High Risk
16%
Hormone Receptor-negative Breast Cancer
16%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
BRCA2
87%
MicroRNA
50%
Single-Nucleotide Polymorphism
36%
Genetic Divergence
33%
MLH1
33%
Single Nucleotide Polymorphism
31%
IMP3
30%
MSH2
25%
Genomics
24%
Genetics
23%
Human Genome
20%
Allele
20%
Population
18%
Missense
18%
Pedigree
16%
Ribonucleoprotein
16%
Gene Fusion
16%
Genetic Screening
16%
RNA
16%
Genetic Variation
16%
Hormone Receptor
16%
MSH6
16%
Penetrance
16%
DNA Modification
16%
HMGA2
16%
Heterozygote
16%
Genetic Carrier
16%
Cohort Study
16%
Messenger RNA
16%
Genetic Disorder
16%
Genotyping
15%
Medicine and Dentistry
Ovarian Cancer
33%
Cancer Risk
21%
Cancer Susceptibility
19%
Aspiration Cytology
16%
Von Hippel-Lindau Disease
16%
Messenger RNA
16%
Protein Binding
16%
Krukenberg Tumor
16%
Genetic Variation
16%
TNF Inhibitor
16%
BRCA2
16%
Infliximab
16%
BRCA1
16%
Monozygotic Twin
16%
